These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24888961)

  • 1. Authors' reply: Prognostic significance of mean platelet volume in epithelial ovarian cancer.
    Ma XG; Wang YM; Xue FX
    J Obstet Gynaecol Res; 2014 Jun; 40(6):1832. PubMed ID: 24888961
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet values measurement. What we know about it?
    Unlu BS; Keles I; Acay A
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1955. PubMed ID: 25056477
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic significance of thrombocytosis, platelet parameters and aggregation rates in epithelial ovarian cancer.
    Ma X; Wang Y; Sheng H; Tian W; Qi Z; Teng F; Xue F
    J Obstet Gynaecol Res; 2014 Jan; 40(1):178-83. PubMed ID: 24102732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of preoperative hyponatremia and thrombocytosis in patients with epithelial ovarian cancer.
    Hefler-Frischmuth K; Grimm C; Gensthaler L; Reiser E; Schwameis R; Hefler LA
    Wien Klin Wochenschr; 2018 Oct; 130(19-20):575-580. PubMed ID: 30178070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraneoplastic thrombocytosis in ovarian cancer.
    Naina HV; Harris S
    N Engl J Med; 2012 May; 366(19):1840; author reply 1840. PubMed ID: 22571210
    [No Abstract]   [Full Text] [Related]  

  • 6. The prognostic significance of thrombocytosis in ovarian cancer.
    Słabuszewska-Jóźwiak A; Dmoch-Gajzlerska E; Kozakiewicz B; Jakiel G
    Ann Agric Environ Med; 2015; 22(4):731-5. PubMed ID: 26706987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets are not hyperreactive in patients with ovarian cancer.
    Feng S; Kroll MH; Nick AM; Sood AK; Afshar-Kharghan V
    Platelets; 2016 Nov; 27(7):716-718. PubMed ID: 27185008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of platelet aggregation abnormalities in thrombocytosis after thrombocytopheresis.
    Fabris F; Belloni M; Casonato A; Randi M; Ongaro G; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):853-62. PubMed ID: 6176511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disorders of thrombocyte function in tumor patients].
    Schenk H; Fereberger W
    Acta Med Austriaca Suppl; 1982; 25():51-4. PubMed ID: 6958156
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of CSF-1 in progression of epithelial ovarian cancer.
    Chambers SK
    Future Oncol; 2009 Nov; 5(9):1429-40. PubMed ID: 19903070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian enzymatically active stromal cells can be a promoter of ovarian surface epithelial tumor.
    Song Z
    Med Hypotheses; 2011 Sep; 77(3):356-8. PubMed ID: 21641729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet function: its clinical significance.
    Ginsburg AD; Aster RH
    Dis Mon; 1970 Sep; ():2-42. PubMed ID: 4918554
    [No Abstract]   [Full Text] [Related]  

  • 13. Ovarian tumors with endocrine manifestations.
    Rao BR; Slotman BJ
    Curr Ther Endocrinol Metab; 1997; 6():260-2. PubMed ID: 9174751
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet abnormalities in hepatobiliary diseases.
    Glassman AB
    Ann Clin Lab Sci; 1990; 20(2):119-22. PubMed ID: 2183703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet adhesiveness after operation.
    Ham JM; Slack WW
    Br J Surg; 1967 May; 54(5):385-9. PubMed ID: 6023095
    [No Abstract]   [Full Text] [Related]  

  • 16. Gonadotropins and ovarian cancer.
    Choi JH; Wong AS; Huang HF; Leung PC
    Endocr Rev; 2007 Jun; 28(4):440-61. PubMed ID: 17463396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hyperthermia on blood platelets in male rats.
    Traystman RJ; Kraus SD
    Proc Soc Exp Biol Med; 1967 Nov; 126(2):390-2. PubMed ID: 4295075
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombocytosis and anaemia in women with recurrent ovarian cancer prior to a second-line chemotherapy.
    Nather A; Mayerhofer K; Grimm C; Hefler L; Leodolter S; Obermair A; Joura EA
    Anticancer Res; 2003; 23(3C):2991-4. PubMed ID: 12926151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet effects on ovarian cancer.
    Davis AN; Afshar-Kharghan V; Sood AK
    Semin Oncol; 2014 Jun; 41(3):378-84. PubMed ID: 25023353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the cell cycle inhibitor p27KIP1 is a new prognostic marker associated with survival in epithelial ovarian tumors.
    Newcomb EW; Sosnow M; Demopoulos RI; Zeleniuch-Jacquotte A; Sorich J; Speyer JL
    Am J Pathol; 1999 Jan; 154(1):119-25. PubMed ID: 9916926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.